Literature DB >> 6189175

Serum beta 2-microglobulin, sialic acid, and C-reactive protein in systemic lupus erythematosus.

C P Maury, T Helve, C Sjöblom.   

Abstract

Serum beta 2-microglobulin (beta 2m), sialic acid and C-reactive protein (CRP) were studied in 58 patients with systemic lupus erythematosus (SLE) on 186 occasions. Serum beta 2m was significantly higher in SLE patients than in control subjects. Increased serum beta 2m levels were seen in 68% of the patients with only extrarenal manifestations of SLE, in 75% of the patients with renal manifestations but normal glomerular filtration rate, and in 100% of the patients with renal failure. Serum beta 2m levels in 12 SLE patients with associated Sjögren's syndrome were similar to those in patients without that syndrome. Serum sialic acid was also significantly increased in the SLE patients. Sixty-one (33%) of the 186 sera were positive for CRP (greater than or equal to 5 mg/l). The CRP elevation was not accompanied by recognized intercurrent infection or other superimposed cause of tissue injury and inflammation in 37 instances (61%). Under such conditions CRP was only moderately increased.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6189175     DOI: 10.1007/bf00286135

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  31 in total

1.  NIH conference. Systemic lupus erythematosus: evolving concepts.

Authors:  J L Decker; A D Steinberg; J L Reinertsen; P H Plotz; J E Balow; J H Klippel
Journal:  Ann Intern Med       Date:  1979-10       Impact factor: 25.391

2.  Serum 2 -microglobulin in renal disease.

Authors:  L Wibell; P E Evrin; I Berggård
Journal:  Nephron       Date:  1973       Impact factor: 2.847

3.  Isolation and properties of a low molecular weight beta-2-globulin occurring in human biological fluids.

Authors:  I Berggård; A G Bearn
Journal:  J Biol Chem       Date:  1968-08-10       Impact factor: 5.157

4.  Serum 2 -microglobulin in various disorders.

Authors:  P E Evrin; L Wibell
Journal:  Clin Chim Acta       Date:  1973-01-24       Impact factor: 3.786

5.  beta 2-Microglobulin levels in serum and urine of rheumatoid arthritis patients on gold therapy.

Authors:  D Latt; J B Weiss; M I Jayson
Journal:  Ann Rheum Dis       Date:  1981-04       Impact factor: 19.103

6.  Serial measurement of beta2 microglobulin, acute phase reactant proteins and the ESR in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia.

Authors:  E H Cooper; R Bunning; S Illingworth; B Späti; J A Child
Journal:  Biomedicine       Date:  1978-07

7.  beta2-Microglobulin production by highly purified human T and B lymphocytes in cell culture stimulated with various mitogens.

Authors:  K Kin; T Kasahara; Y Itoh; I Sakurabayashi; T Kawai; M Morita
Journal:  Immunology       Date:  1979-01       Impact factor: 7.397

8.  Serum pepsinogen I in rheumatic diseases. Reduced levels in Sjögren's syndrome.

Authors:  C P Maury; V Räsänen; A M Teppo; T Helve; O Wegelius
Journal:  Arthritis Rheum       Date:  1982-09

9.  Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE).

Authors:  W Lloyd; P H Schur
Journal:  Medicine (Baltimore)       Date:  1981-05       Impact factor: 1.889

10.  The small subunit of HL-A antigens is beta 2-microglobulin.

Authors:  H M Grey; R T Kubo; S M Colon; M D Poulik; P Cresswell; T Springer; M Turner; J L Strominger
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

View more
  7 in total

Review 1.  beta 2-Microglobulin amyloidosis. A systemic amyloid disease affecting primarily synovium and bone in long-term dialysis patients.

Authors:  C P Maury
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

2.  Different lymphoid cell populations produce varied levels of neopterin, beta 2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumour necrosis factor-alpha.

Authors:  B Hofmann; H Bass; P Nishanian; M Faisal; R A Figlin; G P Sarna; J L Fahey
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

3.  Comparison of serum concentrations of β-trace protein, β2-microglobulin, cystatin C, and creatinine in the US population.

Authors:  Stephen P Juraschek; Josef Coresh; Lesley A Inker; Andrew S Levey; Anna Köttgen; Meredith C Foster; Brad C Astor; John H Eckfeldt; Elizabeth Selvin
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-18       Impact factor: 8.237

4.  Beta-2 microglobulin-based equation for estimating glomerular filtration rates in Japanese children and adolescents.

Authors:  Yohei Ikezumi; Osamu Uemura; Takuhito Nagai; Kenji Ishikura; Shuichi Ito; Hiroshi Hataya; Naoya Fujita; Yuko Akioka; Tetsuji Kaneko; Kazumoto Iijima; Masataka Honda
Journal:  Clin Exp Nephrol       Date:  2014-08-01       Impact factor: 2.801

5.  Serum β2-microglobulin level is a useful indicator of disease activity and hemophagocytic syndrome complication in systemic lupus erythematosus and adult-onset Still's disease.

Authors:  Kuninobu Wakabayashi; Shigeko Inokuma; Erika Matsubara; Kae Onishi; Hiromitsu Asashima; Shinichiro Nakachi; Kiyofumi Hagiwara
Journal:  Clin Rheumatol       Date:  2013-03-16       Impact factor: 2.980

Review 6.  Pentraxins in the activation and regulation of innate immunity.

Authors:  Kenji Daigo; Antonio Inforzato; Isabella Barajon; Cecilia Garlanda; Barbara Bottazzi; Seppo Meri; Alberto Mantovani
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

7.  Sialic acid level reflects the disturbances of glycosylation and acute-phase reaction in rheumatic diseases.

Authors:  Lech Chrostek; Bogdan Cylwik; Ewa Gindzienska-Sieskiewicz; Ewa Gruszewska; Maciej Szmitkowski; Stanislaw Sierakowski
Journal:  Rheumatol Int       Date:  2013-12-18       Impact factor: 2.631

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.